SuperworthOlema Pharmaceuticals shares outstanding OLMA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 104.5M
- On a year earlier
- +22.2%
- more shares
Olema Pharmaceuticals had 104.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 22.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 91.3M | +21% |
| FY2024 | 75.3M | +37% |
| FY2023 | 54.9M | +37% |
| FY2022 | 40.2M | +1% |
| FY2021 | 39.7M | +97% |
| FY2020 | 20.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 104.5M | +22% | |
| Q1 FY26 | 102.8M | +20% | |
| Q4 FY25 | 91.3M | +21% | |
| Q3 FY25 | 85.7M | +50% | |
| Q2 FY25 | 85.5M | +52% | |
| Q1 FY25 | 85.4M | +54% | |
| Q4 FY24 | 75.3M | +37% | |
| Q3 FY24 | 57.3M | +27% | |
| Q2 FY24 | 56.3M | +38% | |
| Q1 FY24 | 55.6M | +38% | |
| Q4 FY23 | 54.9M | +37% | |
| Q3 FY23 | 45M | +12% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Olema Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.